AGP Picks
View all

Pharmaceutical solvents market seen rising to $6.19 billion by 2030

16 hours ago
Pharmaceutical solvents market seen rising to $6.19 billion by 2030
By AI, Created 14:00 UTC, Nov 17, 2026, AGP -

The pharmaceutical solvents market is projected to grow from $4.4 billion in 2025 to $6.19 billion by 2030, driven by drug manufacturing, biopharmaceutical expansion and precision medicine. Asia-Pacific led the market in 2025 and is expected to remain the fastest-growing region.

Why it matters: - Pharmaceutical solvents are a core input for drug manufacturing, formulation, extraction and purification. - Rising demand for high-purity solvents affects how pharmaceutical companies produce generic, specialty and biologic medicines. - The market's growth signals more activity in drug development, biopharmaceutical production and continuous manufacturing.

What happened: - The Business Research Company published its Pharmaceutical Solvents Global Market Report 2026 covering market size, trends and forecasts for 2026-2035. - The market is projected to rise from $4.4 billion in 2025 to $4.73 billion in 2026. - The report forecasts the market will reach $6.19 billion by 2030. - The report projects a 7.4% CAGR in the historical period and a 7.0% CAGR through 2030. - Asia-Pacific was the largest regional market in 2025 and is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Pharmaceutical solvents dissolve active pharmaceutical ingredients and excipients. - The solvents also serve as media for reactions and processing steps in drug production. - Historical growth has been driven by higher pharmaceutical manufacturing activity, stronger demand for drug formulation, more API production, expanded pharmaceutical research, and wider use in extraction and purification. - Forecast growth is tied to demand for generic and specialty drugs, biopharmaceutical manufacturing, continuous pharmaceutical manufacturing, emerging-market capacity expansion and high-purity pharmaceutical-grade solvents. - The report identifies growing use of bio-based solvents, more recycling and reclamation, development of low-toxicity solvents, higher demand for high-purity solvents and broader solvent recovery systems as key trends. - Precision medicine is adding to solvent demand because specialized drugs and biologics require high-purity inputs. - In May 2026, the Personalized Medicine Coalition said the U.S. Food and Drug Administration approved 16 new personalized medicines in 2025. - Those medicines represented about 36% of all newly approved therapeutic molecular entities. - The report says 2026 editions now include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology analysis and future trend analysis. - The company also offered a free sample report and a full report online: More information and the full report.

Between the lines: - Precision medicine is becoming a meaningful demand driver because it raises the need for highly specialized production inputs. - Asia-Pacific's lead suggests pharmaceutical manufacturing growth is shifting toward markets with expanding capacity and healthcare demand. - The report's focus on solvent recovery and bio-based alternatives points to both cost pressure and sustainability pressure in pharmaceutical supply chains.

What's next: - The market is expected to keep growing through 2030 as biopharma output and personalized medicine adoption expand. - Companies are likely to invest more in high-purity, low-toxicity and recyclable solvent systems. - Emerging markets in Asia-Pacific are expected to remain a major source of volume growth.

The bottom line: - Pharmaceutical solvents are moving from a supporting input to a growing strategic category as drug makers scale more complex and cleaner production methods.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.